Complementary and Alternative Care/Dietary Supplements
Omega-3 Fatty Acids, Health Effects on Asthma
March 2004
Clinical Focus*
- What is the evidence for the efficacy of omega-3 fatty acids to improve respiratory outcomes among individuals with asthma?
- What is the evidence that the possible value (efficacy/association) of omega-3 fatty acids in improving respiratory outcomes is dependent on the:
- Specific type of fatty acid (docosahexaenoic acid [DHA, 22:6 n-3], eicosapentaenoic acid [EPA, 20:5 n-3], docosapentaenoic acid [DPA, 22:5 n-3], alpha linolenic acid [ALA, 18:3 n-3], fish, fish oil)?
- Specific source (fish, plant, food, dietary supplement [fish oil, plant oil])?
- Its serving size or dose (fish or dietary supplement)?
- Amount/dose of omega-6 fatty acids given as a cointervention?
- Ratio of omega-6/omega-3 fatty acids used?
- Fatty acid content of blood lipid biomarkers?
- Absolute fatty acid content of the baseline diet?
- Relative fatty acid content of the baseline diet?
- Tissue ratios of fatty acid (omega-6/omega-3) during the investigative period?
- Intervention length?
- Antioxidant use?
- The manufacturer and its product(s) purity or presence of other potentially active agents?
- What is the evidence that, in individuals with asthma, omega-3 fatty acids influence mediators of inflammation which are thought to be related to the pathogenesis of asthma?
- Are omega-3 fatty acids effective in the primary prevention of asthma?
- Among individuals with asthma, do omega-3 fatty acids alter the progression of asthma (i.e., secondary prevention)?
- What is the evidence for adverse events, side effects, or counter-indications associated with omega-3 fatty acid use to treat or prevent asthma (DHA, EPA, DPA, ALA, fish oil, fish)?
- What is the evidence that omega-3 fatty acids are associated with adverse events in specific subpopulations of asthmatic individual such as diabetics?
*Addressed in the summary or evidence report.
Health Effects of Omega-3 Fatty Acids on Asthma
Summary (Publication No. 04-E013-1, March
2004)
Evidence Report (Publication No. 04-E013-2, March 2004)
(PDF Files; File Download)
EPC: University of Ottawa Evidence-based Practice Center
Topic Nominator: Office of Dietary Supplements, National Institutes of Health
Return to Quick Menu: Evidence Report Topics
Return to Evidence-based Practice